Daniel Tenney

4PUBLICATIONS
51CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 08, 2024
Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma.

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik

|Oct 25, 2023
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.

Michael Wichroski, Joseph Benci, Si-Qi Liu

|Sep 26, 2022
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).

Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio

|Feb 15, 2018
Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.

Scott Balsitis, Volodymyr Gali, Pamela J Mason

Pageof 1

Frequent Collaborators

2 joint publications

Jeffrey S Weber

1 joint publications

Dirk Schadendorf

1 joint publications

James Larkin

1 joint publications

Michael Schenker